H2 receptor antagonist famotidine was considered safe after negative results on both the skin prick test (SPT) and oral provocation test (OPT) .
📌 3 Maddede Bu Makale
🎯
Amaç & Hipotez:Proton pump inhibitors (PPIs) are widely prescribed for the management of peptic diseases, including gastroesophageal reflux (GER) and gastric ulcers.
📊
Temel Bulgular & Veri:A 43-year-old woman was admitted to our inpatient clinic with a history of anaphylactic reactions to both pantoprazole and omeprazole.
💡
Sonuç & Katkı:H2 receptor antagonist famotidine was considered safe after negative results on both the skin prick test (SPT) and oral provocation test (OPT) .
Proton pump inhibitors (PPIs) are widely prescribed for the management of peptic diseases, including gastroesophageal reflux (GER) and gastric ulcers. The risk profile of PPIs is acceptable, and hypersensitivity reactions to PPIs are extremely rare. We present a case in which type I hypersensitivity reactions to all PPIs were confirmed. A 43-year-old woman was admitted to our inpatient clinic with a history of anaphylactic reactions to both pantoprazole and omeprazole. Allergy work-up revealed an IgE-mediated hypersensitivity to all proton pump inhibitors. H2 receptor antagonist famotidine was considered safe after negative results on both the skin prick test (SPT) and oral provocation test (OPT) .
Şahinoğlu, E., Bavbek, S. (2026). ANAPHYLAXIS TO PANTOPRAZOLE AND OMEPRAZOLE WITH CROSS-REACTIVITY TO ALL PROTON PUMP INHIBITORS: IDENTIFICATION OF A SAFE ALTERNATIVE. İstanbul Tıp Fakültesi Dergisi, Cilt: 89 Sayı: 2, 145–147. https://doi.org/10.26650/IUITFD.1737119
Bonadonna P, Lombardo C, Bortolami O, Bircher A, Scherer K, Barbaud A, et al. Hypersensitivity to proton pump inhibitors: diagnostic accuracy of skin tests compared to oral provocation test. J Allergy Clin Immunol 2012;130(2):547-9. google scholar
Ward RM, Kearns GL. Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs 2013;15(2):119-31. google scholar
Thomson AB, Sauve MD, Kassam N, Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 2010;16(19):2323-30. google scholar
Strand DS, Kim D, Peura DA. 25 Years of proton pump inhibitors: A comprehensive review. Gut Liver 2017;11(1):27-37. google scholar
Kepil Özdemir S, Yılmaz I, Aydin Ö, Büyüköztürk S, Gelincik A, Demirtürk M, et al. Immediate-type hypersensitivity reactions to proton pump inhibitors: usefulness of skin tests in the diagnosis and assessment of cross-reactivity. Allergy 2013;68(8):1008-14. google scholar
Kepil Özdemir S, Öner Erkekol F, Ünal D, Büyüköztürk S, Gelincik A, Dursun AB, et al. Management of hypersensitivity reactions to proton pump inhibitors: A retrospective experience. Int Arch Allergy Immunol 2016;171(1):54-60. google scholar
Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy. 2002;57(1):45-51. google scholar
Bavbek S, Kepil Özdemir S, Bonadonna P, Atanaskovic-Markovic M, Barbaud A, Brockow K, et al. Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper. Allergy. 2024;79(3):552-64. google scholar
Bose S, Guyer A, Long A, Banerji A. Evaluation and management of hypersensitivity to proton pump inhibitors. Ann Allergy Asthma Immunol 2013;111(6):452-7. google scholar
Lobera T, Navarro B, Del Pozo MD, González I, Blasco A, Escudero R, et al. Nine cases of omeprazole allergy: Cross-reactivity between proton pump inhibitors. J Investig Allergol Clin Immunol 2009;19(1):57-60. google scholar
Elfau MS, Sotillos MG, Clavería LF, Arazuri NS, Ballarin SM, Sanz CC. Study of cross-reactivity between proton pump inhibitors. J Investig Allergol Clin Immunol 2010;20(2):157-61. google scholar
Turedi O, Sozener ZC, Kendirlinan R, Bavbek S. A case of pantoprazole anaphylaxis with cross reactivity to all proton pump inhibitors: Finding a safe alternative. Curr Drug Saf 2017;12(3):198-200. google scholar
Scarpignato C, Hunt RH. Potassium-competitive acid blockers: Current clinical use and future developments. Curr Gastroenterol Rep 2024;26(11):273-93. google scholar
Laine L, DeVault K, Katz P, Mitev S, Lowe J, Hunt B, et al. Vonoprazan Versus Lansoprazole for Healing and Maintenance of Healing of Erosive Esophagitis: A Randomized Trial. Gastroenterology. 2023;164(1):61-71. google scholar
Ward RM, Kearns GL. Proton pump inhibitors in pediatrics: mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs 2013;15(2):119-31. google scholar